Corporate and Transactional
WilmerHale is widely recognized for our preeminence in the representation of technology and life sciences companies in the US and Europe. Our corporate lawyers are renowned for their work in initial public offerings, venture capital, private equity, mergers and acquisitions, strategic alliances, corporate governance matters and the representation of start-up companies.
Our business lawyers draw on the resources of our intellectual property, tax, labor and employment, employee benefits, real estate, bankruptcy, litigation and antitrust practices to provide a one-stop solution to our corporate clients.
Serving a diverse range of clients, from public and private companies to families and individual entrepreneurs, our corporate lawyers:
- Served as issuer counsel or underwriters' counsel in more than 500 public offerings and Rule 144A placements raising over $150 billion since 2000, including as issuer counsel in deals such as CIT Group's $4.6 billion IPO, among the largest IPOs in history, and the IPOs of A123, Accretive Health, Constant Contact, CTC Media, Emergent BioSolutions, Netezza, Ocean Power Technologies, Starent Networks and VistaPrint
- Acted as company counsel or investor counsel in more than 2,400 venture financings raising over $20 billion since 2000, including multimillion-dollar financings by emerging leaders in life sciences, information technology and other industries
- Advised on more than 1,400 M&A deals valued in excess of $700 billion since 2000, including Millennium Pharmaceuticals' $2 billion stock acquisition of COR Pharmaceuticals and the sale of EqualLogic to Dell for $1.4 billion—the largest all-cash purchase price for a venture capital-backed company in history
- Handle hundreds of strategic alliances, joint ventures, outsourcing and licensing transactions each year, including several strategic alliances that have received industry recognition for their importance
- Serve as primary outside counsel for approximately 100 public companies in the US and Europe, advising them on critical securities, disclosure and corporate governance matters
- Have focused on start-up companies and their special needs for decades, and represent more venture-backed companies in the eastern half of the US, and in Europe, than any other law firm
- Represent over 85 venture and buyout fund complexes in their fund formation and ongoing administrative activities, including funds in the US, Israel, Europe and Asia